SEC Filing Details

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

SEC Filing Details

Document Details

Filing Date
Sep 27, 2013
Document Date
Sep 27, 2013
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.